Vigonvita Life Sciences Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	121.14	95.97
Short-Term Investments	0.21	0.24
Cash & Short-Term Investments	121.35	96.22
Cash Growth	26.12%	-
Accounts Receivable	9.86	38.97
Other Receivables	17.24	23.55
Receivables	27.1	62.51
Inventory	7.7	7.33
Prepaid Expenses	0	0.13
Other Current Assets	3.25	-
Total Current Assets	159.4	166.18
Property, Plant & Equipment	483.73	435.36
Other Intangible Assets	53.81	51.67
Long-Term Deferred Charges	23.96	16.41
Other Long-Term Assets	5.05	6.68
Total Assets	725.96	676.3
Accounts Payable	3.5	0.62
Accrued Expenses	40.28	29.26
Current Portion of Long-Term Debt	151.97	133.75
Current Portion of Leases	13.97	10.86
Current Income Taxes Payable	1.3	1.59
Current Unearned Revenue	18.81	7.14
Other Current Liabilities	92.37	102.59
Total Current Liabilities	322.2	285.81
Long-Term Debt	222.16	145.78
Long-Term Leases	28.36	30.64
Long-Term Unearned Revenue	12.88	25.95
Total Liabilities	585.59	488.18
Common Stock	6.6	6.36
Additional Paid-In Capital	336.46	176.7
Retained Earnings	-211.36	0.04
Comprehensive Income & Other	17.8	15.99
Total Common Equity	149.5	199.09
Minority Interest	-9.13	-10.98
Shareholders' Equity	140.37	188.12
Total Liabilities & Equity	725.96	676.3
Total Debt	416.45	321.03
Net Cash (Debt)	-295.11	-224.81
Net Cash Per Share	-2.03	-1.56
Filing Date Shares Outstanding	6.6	144.56
Total Common Shares Outstanding	6.6	144.56
Working Capital	-162.79	-119.63
Book Value Per Share	22.65	1.38
Tangible Book Value	95.69	147.43
Tangible Book Value Per Share	14.50	1.02
Buildings	234.96	0.05
Machinery	68.25	57.46
Construction In Progress	81.01	255.45
Leasehold Improvements	13.29	12.89

Source: S&P Global Market Intelligence. Standard template. Financial Sources.